KaNDy Therapeutics Investors

25 investors on Angel Roster list KaNDy Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the Netherlands, the United States and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name KaNDy Therapeutics can appear together.

Investors listed
25
With verified email
40%
Most common stage
Seed
Top location
Netherlands

Updated October 13, 2026 · How we compile this data

Top 25 KaNDy Therapeutics investors

The most complete profiles first. Showing 25 of 25.

  • Amar PatelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Brian LiuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Karthik BolisettyVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Michael WertVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Sonia ParekhVerified

    Venture Capital, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Garrett HowardVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Josh RichardsonVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Verified email available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Maxwell Bikoff

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carolyn Helms

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Marc

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Zander Liem

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more

    Contact details available

Frequently asked questions

How many KaNDy Therapeutics investors are on Angel Roster?

Angel Roster lists 25 KaNDy Therapeutics investors. 10 of them (40%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (25), Private Equity Firms (11) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do KaNDy Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (13).

Where are KaNDy Therapeutics investors based?

Most are based in the Netherlands (12), the United States (11) and Germany (1).

Which companies have KaNDy Therapeutics investors backed?

The most-backed portfolio companies among them are CoviCept Therapeutics (14), Acorda Therapeutics (14), Milestone Pharmaceuticals (14), Enterprise Therapeutics (14) and ACADIA Pharmaceuticals (14).

How do I contact KaNDy Therapeutics investors?

Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.